我们的网站为什么显示成这样?

可能因为您的浏览器不支持样式,您可以更新您的浏览器到最新版本,以获取对此功能的支持,访问下面的网站,获取关于浏览器的信息:

|本期目录/Table of Contents|

瑞舒伐他汀对急性心肌梗死大鼠NF-κB和IL-6表达的影响(PDF)

《心脏杂志》[ISSN:1009-7236/CN:61-1268/R]

期数:
2011年第4期
页码:
442
栏目:
基础研究
出版日期:
2011-08-25

文章信息/Info

Title:
Effects of rosuvastatin on expressions of NF-κB and interleukin-6 in rats with acute myocardial infarction
作者:
杨慎先万大国杜诗兵
郑州大学第二附属医院心内科,河南 郑州 450014
Author(s):
YANG Shen-xian WAN Da-guo DU Shi-bing
Department of Cardiology, Second Affiliated Hospital, Zhengzhou University, Zhengzhou 450014, Henan, China
关键词:
瑞舒伐他汀核因子-κB白细胞介素6炎症大鼠
Keywords:
rosuvastatin nuclear factor-κB interleukin-6 inflammation rat
分类号:
R972.6
DOI:
61-1268/R.20110503.1153.006
文献标识码:
A
摘要:
目的:探讨瑞舒伐他汀(rosuvastatin,ROS)对大鼠急性心肌梗死(AMI)后心肌组织炎症的影响。方法: 结扎20只雄性Wistar大鼠冠状动脉的左前降支(LAD)建立心梗模型。成功后,随机分为AMI组和ROS干预组,每组10只大鼠。另取10只大鼠作为假手术(Sham)组(仅穿线不结扎)。ROS干预组给予ROS 10 mg/(kg·d)灌胃;其他两组每只大鼠每天给予2 ml生理盐水灌胃。持续4周后,处死动物,取部分心肌非梗死边缘区组织做HE染色观察病理改变;其余心肌组织分别进行免疫组化染色及RT-PCR,检测NF-κB、IL-6及二者mRNA的表达。结果: 心肌组织HE染色显示,与AMI组比较,ROS干预组心肌排列较整齐,心肌纤维断裂较少,心肌纤维样变减少,炎性细胞浸润减轻。Sham组NF-κB和IL-6均无明显表达。AMI组NF-κB和IL-6的mRNA和两种蛋白的表达均显著高于Sham组(P<0.05)。同AMI组相比较,ROS干预组NF-κB、IL-6 mRAN和两种蛋白的表达均显著下降(P<0.05),NF-κB和IL-6的表达呈正相关(r=0.85,0.75)。结论: ROS对AMI大鼠进行干预可调控NF-κB的活性,减少IL-6炎性因子的表达,可改善心肌重构。
Abstract:
AIM:To evaluate the effects of rosuvastatin on inflammation of myocardial tissues in rats with acute myocardial infarction (AMI). METHODS: Twenty male Wistar rats with ligated LAD were used to establish models of AMI and the successfully established models were randomly divided into acute myocardial infarction group (AMI group) and rosuvastatin intervention group (ROS group). Another 10 rats (sham group) were tested with pierced but not ligated LAD. Rats in ROS group were given rosuvastatin by gavage at 10 mg/(kg·day) dose levels, whereas rats in the other two groups were given 2 ml normal saline each day. Four weeks later, noninfarcted myocardial tissues were observed with HE section staining, whereas NF-κB and IL-6 were detected by immunohistochemistry and RT-PCR. RESULTS: HE section staining showed that cardiac tissues were more orderly arrayed. There was less rupture of cardiac tissue fiber, less fibrosis, and the inflammatory cell reaction was milder in the ROS group compared with rats in the AMI group. No expressions of NF-κB and IL-6 were found in sham group. In AMI group, both mRNA expression and protein production of these cytokines were markedly higher than those in sham group (P<0.05). Significant reductions of mRNA expression and protein production of NF-κB and IL-6 were observed in ROS group compared with those in AMI group (P<0.05), NF-κB and IL-6 of the two were positively correlated (r=0.85, 0.78). CONCLUSION: Rosuvastatin helps regulate the activation of NF-κB and reduces the expression of IL-6 in AMI rat; therefore, it is beneficial to the ventricular remodeling improvement.

参考文献/References

[1]Dohi T,Miyauchi K,Okazaki S,et al.Early intensive statin treatment for six months improves long-term clinical outcomes in patients with acute coronary syndrome (Extended-ESTABLISH trial): A follow-up study[J].Atherosclerosis,2010,210(2):497-502.
[2]Forrester JS,Libby P.The inflammation hypothesis and its potential relevance to statin therapy[J].Am J Cardiol,2007, 99(5):732-738.
[3]Li JJ,Li YS,Chu JM,et al.Changes of plasma inflammatory markers after withdrawal of statin therapy in patients with hyperlipidemia[J].Clin Chim Acta,2006,366(1-2):269-273.
[4]刘涛,王伟,赵明镜,等.左冠状动脉前降支结扎法制作大鼠心肌梗死模型[J].实验动物与比较医学,2009,29(2):120-123.
[5]Susic D,Varagic J,Ahn J,et al.Beneficial pleiotropic vascular effects of rosuvastatin in two hypertensive models[J].Am Coll Cardiol,2003,42(6):1091-1097.
[6]Li TS,Takahashi M,Suzuki R,et al.Pravastatin improves remodeling and cardiac function after myocardial infarction by an antiinflammatory mechanism rather than by the induction of angiogenesis[J].Ann Thorac Surg,2006,81(6):2217-2225.
[7]张军,贾国良,王海昌,等.大鼠心肌梗死后心肌NF-κB、MMP-2和TIMP-2表达变化及其意义[J].心脏杂志,2006,18(1):54-59.
[8]Tawfik MK, Ghattas MH,Abo-Elmatty DM,et al.Atorvastatin restores the balance between pro-inflammatory and anti-inflammatory mediators in rats with acute myocardial infarction[J].Eur Rev Med Pharmacol Sci,2010,14(6):499-506.
[9]Gissi-HF Investigators,Tavazzi L,Maggioni AP,et al.Effect of rosuvastatin in patients with chronic heart failure (the GISSI-HF trial): a randomised, double-blind, placebo-controlled trial[J].Lancet,2008,372(9645):1231-1239.

备注/Memo

备注/Memo:
收稿日期:2009-823.通讯作者:万大国,教授,主要从事冠心病和心脏电生理诊治研究Email:wandaguo@hotmail.com 作者简介:杨慎先,副主任医师,硕士Email:ysx892@sohu.com
更新日期/Last Update: 2011-06-02